vTv Therapeutics Inc (VTVT) Stock Price, Quote, News & History

VTVTNASDAQ
$33.91
0.020.06%
At close: Aug 24, 5:00 PM EST
$33.92
0.030.09%
Pre-Market: 4:01 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-16.76M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
77.48M
Free Cash Flow (TTM)
-16.76M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
60.72M

Analyst Trends and Forecast

2
Mar
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$35.93M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.42
PB Ratio (TTM)
1.71
Earnings Yield % (TTM)
-2.21%
Earnings Yield % (FWD)
-4.75%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$19.89

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$86.64M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$33.91
Volume / Avg.
1.00 / 70.97K
Day Range
- - -
52 Wk Range
15.79 - 44.00
Market Cap
$134.12M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
6.91%
Days to Cover
1.48

About

Sector
Health Care
Industry
Biotechnology
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TT...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy vTv Therapeutics (VTVT) stock?

A

You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are vTv Therapeutics (VTVT) competitors?

Q

What is the forecast, or price target, for vTv Therapeutics (VTVT) stock?

A

vTv Therapeutics has a consensus price target of $50.50.

Q

What is the current price for vTv Therapeutics (VTVT)?

A

The stock price for vTv Therapeutics (NASDAQ: VTVT) is $33.92 last updated August 25, 2026 at 4:01 PM EDT.

Q

Does vTv Therapeutics (VTVT) pay a dividend?

A

There are no upcoming dividends for vTv Therapeutics.

Q

When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?

A

vTv Therapeutics does not have any upcoming earnings scheduled.

Q

Is vTv Therapeutics (VTVT) going to split?

A

There is no upcoming split for vTv Therapeutics.

Q

What sector and industry does vTv Therapeutics (VTVT) operate in?

A

vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.